[EPO] CROSS-SPECIFIC ANTIGEN BINDING PROTEINS (ABP) TARGETING LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B1 (LILRB1) AND LILRB2, COMBINATIONS AND USES THEREOF

Part of

Early Phase Immune Therapeutics Trials